195
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Hispanic Ethnicity and Cervical Cancer Precursors Among Low-Income Women in Arizona

, , , &
Pages 929-937 | Published online: 19 Oct 2021

References

  • Hallowell BD, Endeshaw M, McKenna MT, Senkomago V, Razzaghi H, Saraiya M. Cervical cancer death rates among U.S.- and foreign-born women: U.S., 2005–2014. Am J Prev Med. 2019;56(6):869–874. doi:10.1016/j.amepre.2019.01.007
  • Burdette AM, Webb NS, Hill TD, Jokinen-Gordon H. Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress? Public Health (London). 2016;142:167–176. doi:10.1016/j.puhe.2016.07.009.
  • Jandorf L, Bursac Z, Pulley LV, Trevina M, Castillo A, Erwin DO. Breast and cervical cancer screening among Hispanics attending culturally specific educational programs. Prog Community Health Partnersh Res Educ Action. 2008;2(3):95–204. doi:10.1353/cpr.0.0034
  • American Cancer Society. Cancer facts and figures for Hispanics/Latinos 2018–2020. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-hispanics-and-latinos/cancer-facts-and-figures-for-hispanics-andlatinos-2018-2020.pdf. Accessed January 11, 2021.
  • U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool, based on 2019 submission data (1999–2017): U.S. department of health and human services, centers for disease control and prevention and national cancer institute; 2020. Available from: www.cdc.gov/cancer/dataviz. Accessed January 14, 2021.
  • Cooper DB, McCathran CE. Cervical dysplasia; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430859. Accessed January 10, 2021.
  • Oregon Health Authority. Human papillomavirus infections in Oregon, 2018. CD Summary. 2018;67(7). www.oregon.gov/oha/PH/DISEASESCONDITIONS/COMMUNICABLEDISEASE/CDSUMMARYNEWSLETTER/Documents/2018/ohd6707.pdf. Accessed, 2021.
  • Shah R, Nwankwo C, Kwon Y, Corman SL. Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey. J Womens Health. 2020;29(6):799–805. doi:10.1089/jwh.2019.7858
  • Desravines N, Miele K, Carlson R, Chibwesha C, Rahangdale L. Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: a narrative review. Gynecol Oncol Rep. 2020;33:1. doi:10.1016/j.gore.2020.100608
  • Maguire P, McCarthy C, Molony P, et al. Large loop excision of the transformation zone and preterm delivery over a decade in a major women’s hospital. Ir J Med Sci. 2019;188(2):579–581. doi:10.1007/s11845-018-1893-z
  • Maina G, Ribaldone R, Danese S, et al. Obstetric outcomes in patients who have undergone excisional treatment for high-grade cervical squamous intra-epithelial neoplasia. Eur J Obstet Gynecol. 2019;236:210–213. doi:10.1016/j.ejogrb.2019.02.025
  • Rask M, Swahnberg K, Lindell G, Oscarsson M. Women’s experiences of abnormal pap smear results - a Qualitative Study. Sex Reprod Health. 2017;12:3–8. doi:10.1016/j.srhc.2017.01.002
  • Thangarajah F, Einzmann T, Bergauer F, et al. Cervical screening program and the psychological impact of an abnormal pap smear: a self-assessment questionnaire study of 590 patients. Arch Gynecol Obstet. 2016;293(2):391–398. doi:10.1007/s00404-015-3821-z
  • Guardado-Estrada M, Juarez-Torres E, Roman-Bassaure E, et al. The distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancer. PLoS One. 2014;9(10):1–12. doi:10.1371/journal.pone.0109406
  • Herrera DG, Schiefelbein EL, Smith R, et al. Cervical cancer screening in the US–Mexico border region: a binational analysis. Matern Child Health J. 2012;16(2):298–306. doi:10.1007/s10995-012-1130-8
  • Reininger BM, Barroso CS, Mitchell-Bennett L, et al. Social-ecological influences on health-care access and navigation among persons of Mexican descent living on the U.S./Mexico border. J Immigr Minor Health. 2014;16(2):218–228. doi:10.1007/s10903-012-9714-3
  • Moore de Peralta A, Holaday B, Hadoto IM. Cues to cervical cancer screening among U.S. Hispanic women. HCCI. 2017;15(1):5–12. doi:10.1177/1540415316682494
  • Kiser L, Butler J. Improving equitable access to cervical cancer screening and management. Am J Nurs. 2020;120(11):58–67. doi:10.1097/01.NAJ.0000721944.67166.17
  • Colby SL, Ortman JM. Projections of the size and composition of the U.S. population: 2014 to 2060. Current Population Reports 2015. U.S. Census Bureau: Washington, DC; 2014:25–1143.
  • Krogstad JM. Hispanics have accounted for more than half of total U.S. population growth since 2010; 2020. Available from: https://www.pewresearch.org/fact-tank/2020/07/10/hispanics-have-accounted-for-more-than-half-of-total-u-s-population-growth-since-2010/. Accessed January 14, 2020.
  • Cancer prevention and control programs. Arizona department of health services web site. Available from: http://www.azdhs.gov/prevention/health-systems-development/cancer-prevention-control/index.php#healthcheck-home. Accessed February 1, 2018.
  • Siegl EJ, Miller JW, Khan K, Harris SE. Quality assurance through quality improvement and professional development in the national breast and cervical cancer early detection program. Cancer. 2014;120(S16):2584–2590. doi:10.1002/cncr.28822.
  • Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Using data to effectively manage a national screening program. Cancer. 2014;120(S16):2575–2583. doi:10.1002/cncr.28821.
  • Luhn P, Walker J, Schiffman M, et al. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2012;128(2):265–270. doi:10.1016/j.ygyno.2012.11.003.
  • Roura E, Castellsagué X, Pawlita M, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer. 2014;135(2):453. doi:10.1002/ijc.28666.
  • Niccolai LM, Russ C, Julian PJ, et al. Individual and geographic disparities in human papillomavirus types 16/18 in high‐grade cervical lesions. Cancer. 2013;119(16):3052–3058. doi:10.1002/cncr.28038.
  • Niccolai LM, Julian PJ, Bilinski A, et al. Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008–2009. Am J Public Health. 2013;103(1):156–163. doi:10.2105/AJPH.2011.300447.
  • Gargano JW, Nisenbaum R, Lee DR, et al. Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Cancer Epidemiol Biomarker Preven. 2012;21(1):111–121. doi:10.1158/1055-9965.EPI-11-0664.
  • StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019.
  • Henk HJ, Insinga RP, Singhal PK, Darkow T. Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population. J Low Genit Tract Dis. 2010;14(1):29–36. doi:10.1097/LGT.0b013e3181ac05e9
  • Gomez N, Guendelman S, Harley KG, et al. Nativity and neighborhood characteristics and cervical cancer stage at diagnosis and survival outcomes among Hispanic women in California. Am J Public Health. 2015;105(3):538–545. doi:10.2105/AJPH.2014.302261
  • Baezconde-Garbanati L, Murphy ST, Moran MG, et al. Reducing the excess burden of cervical cancer among Latinas: translating science into health promotion initiatives. Calif J Health Promot. 2014;11(1):45–57. doi:10.32398/cjhp.v11i1.1517
  • Shoemaker ML, White MC. Breast and cervical cancer screening among Hispanic subgroups in the USA: estimates from the national health interview survey 2008, 2010, and 2013. Cancer Causes Control. 2016;27(3):453–457. doi:10.1007/s10552-016-0718-5
  • Benard VB, Royalty J, Saraiya M, Rockwell T, Heisel W. The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women. Cancer Causes Control. 2015;26(5):713–719. doi:10.1007/s10552-015-0542-3
  • Gage JC, Hunt WC, Schiffman M, et al. Similar risk patterns after cervical screening in two large U.S. populations: implications for clinical guidelines. Obstet Gynecol. 2015;128(6):1248–1257. doi:10.1097/AOG.0000000000001721
  • Fang JH, Yu XM, Zhang SH, Yang Y. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies. J Can Res Ther. 2018;14(Suppl S1):184–189. doi:10.4103/0973-1482.179190
  • McIntyre-Seltman K, Castle PE, Guido R, Schiffman M, Cosette M, Wheeler M. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA–positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarker. 2005;14(5):1165–1170. doi:10.1158/1055-9965.EPI-04-0918
  • James SA, Meier EM, Wagener TL, et al. E-Cigarettes for immediate smoking substitution in women diagnosed with cervical dysplasia and associated disorders. Int J Environ Res Public Health. 2016;288(13):1–11. doi:10.3390/ijerph13030288
  • Miller JW, Royalty J, Henley J, et al. Breast and cervical cancers diagnosed and stage at diagnosis among women served through the national breast and cervical cancer early detection program. Cancer Causes Control. 2015;26(5):741–747. doi:10.1007/s10552-015-0543-2
  • Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12):1028–1035. doi:10.1111/j.1525-1497.2003.20807.x
  • Shoemaker ML, White MC. Breast and cervical cancer screening among Hispanic subgroups in the USA estimates from the national health interview survey 2008, 2010, and 2013. Cancer Causes Control. 2017;27(3):453–457. doi:10.1007/s10552-016-0718-5
  • McClung NM, Gargano JW, Park IU, et al. Estimated number of cases of high-grade cervical lesions diagnosed among women – United States, 2008 and 2016. MMWR Morb Wkly Rep. 2019;68(15):337–343. doi:10.15585/mmwr.mm6815a1
  • Miller MJ. Impact of COVID-19 on cervical cancer screening rates among women aged 21–61 years. MMWR. 2021;70(4):109–111.